|
시장보고서
상품코드
1873688
세계의 통증 관리용 고주파 절제술 : 시장 점유율과 순위, 전체 판매량 및 수요 예측(2025-2031년)Radiofrequency Ablation for Pain Management - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 |
||||||
QYResearch
세계의 통증 관리용 고주파 절제술 시장 규모는 2024년에 3억 3,200만 달러로 추정되며, 2025-2031년의 예측 기간에 CAGR 10.0%로 성장하여 2031년까지 6억 4,100만 달러로 확대될 것으로 예측됩니다.
고주파 소작요법은 뇌에 통증 신호를 전달하는 신경섬유를 파괴하는 최소침습적 시술입니다. 특히 허리, 목, 관절염 관절 등의 만성 통증으로 고생하는 분들에게 지속적인 통증 완화를 가져다 줄 수 있습니다. 근절제술이라고도 불리는 고주파 소작요법은 열을 이용해 통증 전달을 감소시키거나 차단하는 비수술적, 저침습적 치료법입니다. 고주파 에너지로 통증의 원인이 되는 신경조직을 소작(소작)함으로써 뇌로의 통증 신호 전달을 원천적으로 차단합니다. 이 치료법은 척추관절증(척추증), 천장관절염 등 만성 통증 및 질환 치료에 가장 널리 사용되고 있습니다. 또한 목, 허리, 무릎, 골반, 말초신경 통증에도 적용됩니다. 고주파 소작술의 장점으로는 수술을 피할 수 있고, 즉각적인 통증 완화, 회복 기간이 거의 또는 전혀 필요하지 않으며, 진통제의 필요성이 감소하고, 기능의 개선이 기대되며, 직장이나 다른 활동으로의 조기 복귀가 가능하다는 점 등이 있습니다.
통증 관리용 고주파 절제술 시장은 관절염, 요통, 신경병증성 질환과 같은 만성 통증 질환의 유병률 증가, 특히 고령화 인구 증가에 힘입어 성장하고 있습니다. 환자와 의료시스템이 통증 관리에 있어 저침습적이고 오피오이드를 사용하지 않는 대체 요법을 점점 더 많이 요구하고 있는 가운데, RFA는 비용 효율적이고 지속 가능한 솔루션을 제공합니다. 영상 유도 절제술, 냉각식 RFA 시스템 등의 기술 발전으로 정확도와 치료 결과가 향상되어 외래 진료소 및 수술센터에서의 도입이 더욱 가속화되고 있습니다.
이러한 장점에도 불구하고 RFA 시장은 몇 가지 문제에 직면해 있습니다. 특히 중저소득 지역에서는 고가의 장비 비용과 시술 비용이 접근성을 제한할 수 있습니다. 또한, 일부 국가에서는 보상 제도의 불균형과 엄격한 규제 절차가 보급을 지연시키는 요인이 될 수 있습니다. 환자의 해부학적 구조에 따른 효과의 편차, 시간 경과에 따른 신경 재생, 재시술의 필요성과 같은 임상적 한계도 의사의 선택과 환자 만족도에 영향을 미칠 수 있습니다. 지속적인 성장을 위해서는 의료진과 환자에 대한 RFA의 장점과 한계에 대한 교육이 여전히 필수적입니다.
이 보고서는 통증 관리를 위한 전파 소작 요법 세계 시장에 대해 총 매출액, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고, 지역/국가, 유형 및 용도별 분석을 종합적으로 제시하는 것을 목적으로 합니다.
이 보고서는 2024년을 기준 연도로 하여 2020-2031년의 과거 데이터와 예측 데이터를 포함하는 2024년까지의 매출 수익으로 통증 관리용 고주파 소작 요법 시장 규모, 추정치 및 예측치를 제시합니다. 정량적, 정성적 분석을 통해 독자들이 비즈니스/성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 포지셔닝 분석, 통증관리용 고주파 소작요법에 대한 정보에 입각한 비즈니스 의사결정을 내릴 수 있도록 돕습니다.
시장 세분화
기업별
- Abbott
- Avanos Medical
- Stryker
- Boston Scientific
- Medtronic
- Diros Technology
유형별 부문
- RF 발생 장비
- 재이용 가능 제품
- 일회용 제품
용도별 부문
- 병원
- 진료소
- 기타
지역별
- 북미
- 미국
- 캐나다
- 아시아태평양
- 중국
- 일본
- 한국
- 동남아시아
- 인도
- 호주
- 기타 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 네덜란드
- 북유럽 국가
- 기타 유럽
- 라틴아메리카
- 멕시코
- 브라질
- 기타 라틴아메리카
- 중동 및 아프리카
- 튀르키예
- 사우디아라비아
- 아랍에미리트(UAE)
- 기타 중동 및 아프리카
자주 묻는 질문
The global market for Radiofrequency Ablation for Pain Management was estimated to be worth US$ 332 million in 2024 and is forecast to a readjusted size of US$ 641 million by 2031 with a CAGR of 10.0% during the forecast period 2025-2031.
A radiofrequency ablation is a minimally invasive procedure that destroys the nerve fibers carrying pain signals to the brain. It can provide lasting relief for people with chronic pain, especially in the lower back, neck and arthritic joints. Radiofrequency ablation, also called rhizotomy, is a nonsurgical, minimally invasive procedure that uses heat to reduce or stop the transmission of pain. Radiofrequency waves ablate, or "burn," the nerve that is causing the pain, essentially eliminating the transmission of pain signals to the brain. This procedure is most commonly used to treat chronic pain and conditions such as arthritis of the spine (spondylosis) and sacroilitis. It is also used to treat neck, back, knee, pelvic and peripheral nerve pain. The benefits of radiofrequency ablation include avoiding surgery, immediate pain relief, little to no recovery time, decreased need for pain medication, improved function, and a quicker return to work and other activities.
The radiofrequency ablation (RFA) for pain management market is driven by the growing prevalence of chronic pain conditions, such as arthritis, lower back pain, and neuropathic disorders, especially among the aging population. As patients and healthcare systems increasingly seek minimally invasive, opioid-free alternatives to manage pain, RFA offers a cost-effective and long-lasting solution. Technological advancements, such as image-guided ablation and cooled RFA systems, are enhancing precision and outcomes, further accelerating adoption in both outpatient clinics and surgical centers.
Despite its benefits, the RFA market faces several challenges. High equipment costs and procedural expenses can limit accessibility, particularly in low- and middle-income regions. Additionally, reimbursement variability and strict regulatory pathways in some countries can slow adoption. Clinical limitations-such as varying effectiveness based on patient anatomy, nerve regeneration over time, and the need for repeat procedures-may also impact physician preference and patient satisfaction. Educating healthcare providers and patients on the benefits and limitations of RFA remains essential for sustained growth.
This report aims to provide a comprehensive presentation of the global market for Radiofrequency Ablation for Pain Management, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Radiofrequency Ablation for Pain Management by region & country, by Type, and by Application.
The Radiofrequency Ablation for Pain Management market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiofrequency Ablation for Pain Management.
Market Segmentation
By Company
- Abbott
- Avanos Medical
- Stryker
- Boston Scientific
- Medtronic
- Diros Technology
Segment by Type
- RF Generators
- Reusable Products
- Disposable Products
Segment by Application
- Hospital
- Clinic
- Other
By Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Radiofrequency Ablation for Pain Management company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Radiofrequency Ablation for Pain Management in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Radiofrequency Ablation for Pain Management in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
- 1.1 Radiofrequency Ablation for Pain Management Product Introduction
- 1.2 Global Radiofrequency Ablation for Pain Management Market Size Forecast (2020-2031)
- 1.3 Radiofrequency Ablation for Pain Management Market Trends & Drivers
- 1.3.1 Radiofrequency Ablation for Pain Management Industry Trends
- 1.3.2 Radiofrequency Ablation for Pain Management Market Drivers & Opportunity
- 1.3.3 Radiofrequency Ablation for Pain Management Market Challenges
- 1.3.4 Radiofrequency Ablation for Pain Management Market Restraints
- 1.4 Assumptions and Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
2 Competitive Analysis by Company
- 2.1 Global Radiofrequency Ablation for Pain Management Players Revenue Ranking (2024)
- 2.2 Global Radiofrequency Ablation for Pain Management Revenue by Company (2020-2025)
- 2.3 Key Companies Radiofrequency Ablation for Pain Management Manufacturing Base Distribution and Headquarters
- 2.4 Key Companies Radiofrequency Ablation for Pain Management Product Offered
- 2.5 Key Companies Time to Begin Mass Production of Radiofrequency Ablation for Pain Management
- 2.6 Radiofrequency Ablation for Pain Management Market Competitive Analysis
- 2.6.1 Radiofrequency Ablation for Pain Management Market Concentration Rate (2020-2025)
- 2.6.2 Global 5 and 10 Largest Companies by Radiofrequency Ablation for Pain Management Revenue in 2024
- 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiofrequency Ablation for Pain Management as of 2024)
- 2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
- 3.1 Introduction by Type
- 3.1.1 RF Generators
- 3.1.2 Reusable Products
- 3.1.3 Disposable Products
- 3.2 Global Radiofrequency Ablation for Pain Management Sales Value by Type
- 3.2.1 Global Radiofrequency Ablation for Pain Management Sales Value by Type (2020 VS 2024 VS 2031)
- 3.2.2 Global Radiofrequency Ablation for Pain Management Sales Value, by Type (2020-2031)
- 3.2.3 Global Radiofrequency Ablation for Pain Management Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
- 4.1 Introduction by Application
- 4.1.1 Hospital
- 4.1.2 Clinic
- 4.1.3 Other
- 4.2 Global Radiofrequency Ablation for Pain Management Sales Value by Application
- 4.2.1 Global Radiofrequency Ablation for Pain Management Sales Value by Application (2020 VS 2024 VS 2031)
- 4.2.2 Global Radiofrequency Ablation for Pain Management Sales Value, by Application (2020-2031)
- 4.2.3 Global Radiofrequency Ablation for Pain Management Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
- 5.1 Global Radiofrequency Ablation for Pain Management Sales Value by Region
- 5.1.1 Global Radiofrequency Ablation for Pain Management Sales Value by Region: 2020 VS 2024 VS 2031
- 5.1.2 Global Radiofrequency Ablation for Pain Management Sales Value by Region (2020-2025)
- 5.1.3 Global Radiofrequency Ablation for Pain Management Sales Value by Region (2026-2031)
- 5.1.4 Global Radiofrequency Ablation for Pain Management Sales Value by Region (%), (2020-2031)
- 5.2 North America
- 5.2.1 North America Radiofrequency Ablation for Pain Management Sales Value, 2020-2031
- 5.2.2 North America Radiofrequency Ablation for Pain Management Sales Value by Country (%), 2024 VS 2031
- 5.3 Europe
- 5.3.1 Europe Radiofrequency Ablation for Pain Management Sales Value, 2020-2031
- 5.3.2 Europe Radiofrequency Ablation for Pain Management Sales Value by Country (%), 2024 VS 2031
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Radiofrequency Ablation for Pain Management Sales Value, 2020-2031
- 5.4.2 Asia Pacific Radiofrequency Ablation for Pain Management Sales Value by Region (%), 2024 VS 2031
- 5.5 South America
- 5.5.1 South America Radiofrequency Ablation for Pain Management Sales Value, 2020-2031
- 5.5.2 South America Radiofrequency Ablation for Pain Management Sales Value by Country (%), 2024 VS 2031
- 5.6 Middle East & Africa
- 5.6.1 Middle East & Africa Radiofrequency Ablation for Pain Management Sales Value, 2020-2031
- 5.6.2 Middle East & Africa Radiofrequency Ablation for Pain Management Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
- 6.1 Key Countries/Regions Radiofrequency Ablation for Pain Management Sales Value Growth Trends, 2020 VS 2024 VS 2031
- 6.2 Key Countries/Regions Radiofrequency Ablation for Pain Management Sales Value, 2020-2031
- 6.3 United States
- 6.3.1 United States Radiofrequency Ablation for Pain Management Sales Value, 2020-2031
- 6.3.2 United States Radiofrequency Ablation for Pain Management Sales Value by Type (%), 2024 VS 2031
- 6.3.3 United States Radiofrequency Ablation for Pain Management Sales Value by Application, 2024 VS 2031
- 6.4 Europe
- 6.4.1 Europe Radiofrequency Ablation for Pain Management Sales Value, 2020-2031
- 6.4.2 Europe Radiofrequency Ablation for Pain Management Sales Value by Type (%), 2024 VS 2031
- 6.4.3 Europe Radiofrequency Ablation for Pain Management Sales Value by Application, 2024 VS 2031
- 6.5 China
- 6.5.1 China Radiofrequency Ablation for Pain Management Sales Value, 2020-2031
- 6.5.2 China Radiofrequency Ablation for Pain Management Sales Value by Type (%), 2024 VS 2031
- 6.5.3 China Radiofrequency Ablation for Pain Management Sales Value by Application, 2024 VS 2031
- 6.6 Japan
- 6.6.1 Japan Radiofrequency Ablation for Pain Management Sales Value, 2020-2031
- 6.6.2 Japan Radiofrequency Ablation for Pain Management Sales Value by Type (%), 2024 VS 2031
- 6.6.3 Japan Radiofrequency Ablation for Pain Management Sales Value by Application, 2024 VS 2031
- 6.7 South Korea
- 6.7.1 South Korea Radiofrequency Ablation for Pain Management Sales Value, 2020-2031
- 6.7.2 South Korea Radiofrequency Ablation for Pain Management Sales Value by Type (%), 2024 VS 2031
- 6.7.3 South Korea Radiofrequency Ablation for Pain Management Sales Value by Application, 2024 VS 2031
- 6.8 Southeast Asia
- 6.8.1 Southeast Asia Radiofrequency Ablation for Pain Management Sales Value, 2020-2031
- 6.8.2 Southeast Asia Radiofrequency Ablation for Pain Management Sales Value by Type (%), 2024 VS 2031
- 6.8.3 Southeast Asia Radiofrequency Ablation for Pain Management Sales Value by Application, 2024 VS 2031
- 6.9 India
- 6.9.1 India Radiofrequency Ablation for Pain Management Sales Value, 2020-2031
- 6.9.2 India Radiofrequency Ablation for Pain Management Sales Value by Type (%), 2024 VS 2031
- 6.9.3 India Radiofrequency Ablation for Pain Management Sales Value by Application, 2024 VS 2031
7 Company Profiles
- 7.1 Abbott
- 7.1.1 Abbott Profile
- 7.1.2 Abbott Main Business
- 7.1.3 Abbott Radiofrequency Ablation for Pain Management Products, Services and Solutions
- 7.1.4 Abbott Radiofrequency Ablation for Pain Management Revenue (US$ Million) & (2020-2025)
- 7.1.5 Abbott Recent Developments
- 7.2 Avanos Medical
- 7.2.1 Avanos Medical Profile
- 7.2.2 Avanos Medical Main Business
- 7.2.3 Avanos Medical Radiofrequency Ablation for Pain Management Products, Services and Solutions
- 7.2.4 Avanos Medical Radiofrequency Ablation for Pain Management Revenue (US$ Million) & (2020-2025)
- 7.2.5 Avanos Medical Recent Developments
- 7.3 Stryker
- 7.3.1 Stryker Profile
- 7.3.2 Stryker Main Business
- 7.3.3 Stryker Radiofrequency Ablation for Pain Management Products, Services and Solutions
- 7.3.4 Stryker Radiofrequency Ablation for Pain Management Revenue (US$ Million) & (2020-2025)
- 7.3.5 Stryker Recent Developments
- 7.4 Boston Scientific
- 7.4.1 Boston Scientific Profile
- 7.4.2 Boston Scientific Main Business
- 7.4.3 Boston Scientific Radiofrequency Ablation for Pain Management Products, Services and Solutions
- 7.4.4 Boston Scientific Radiofrequency Ablation for Pain Management Revenue (US$ Million) & (2020-2025)
- 7.4.5 Boston Scientific Recent Developments
- 7.5 Medtronic
- 7.5.1 Medtronic Profile
- 7.5.2 Medtronic Main Business
- 7.5.3 Medtronic Radiofrequency Ablation for Pain Management Products, Services and Solutions
- 7.5.4 Medtronic Radiofrequency Ablation for Pain Management Revenue (US$ Million) & (2020-2025)
- 7.5.5 Medtronic Recent Developments
- 7.6 Diros Technology
- 7.6.1 Diros Technology Profile
- 7.6.2 Diros Technology Main Business
- 7.6.3 Diros Technology Radiofrequency Ablation for Pain Management Products, Services and Solutions
- 7.6.4 Diros Technology Radiofrequency Ablation for Pain Management Revenue (US$ Million) & (2020-2025)
- 7.6.5 Diros Technology Recent Developments
8 Industry Chain Analysis
- 8.1 Radiofrequency Ablation for Pain Management Industrial Chain
- 8.2 Radiofrequency Ablation for Pain Management Upstream Analysis
- 8.2.1 Key Raw Materials
- 8.2.2 Raw Materials Key Suppliers
- 8.2.3 Manufacturing Cost Structure
- 8.3 Midstream Analysis
- 8.4 Downstream Analysis (Customers Analysis)
- 8.5 Sales Model and Sales Channels
- 8.5.1 Radiofrequency Ablation for Pain Management Sales Model
- 8.5.2 Sales Channel
- 8.5.3 Radiofrequency Ablation for Pain Management Distributors
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.1.1 Research Programs/Design
- 10.1.1.2 Market Size Estimation
- 10.1.1.3 Market Breakdown and Data Triangulation
- 10.1.2 Data Source
- 10.1.2.1 Secondary Sources
- 10.1.2.2 Primary Sources
- 10.1.1 Methodology/Research Approach
- 10.2 Author Details
- 10.3 Disclaimer
